Publications by authors named "Ruth Wester"

Claim this Profile
M
Mobilization of hematopoietic stem cells using G-CSF with or without cyclophosphamide before autologous stem cell transplantation in patients with newly diagnosed multiple myeloma receiving induction therapy with or without daratumumab.
Cathelijne Fokkema, Marjolein K Appelman, Niels Veldhoen, Annie Spelt, Bronno van der Holt, Ruth Wester

Bone Marrow Transplant· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN-HARMONY Alliance platform.
Adrian Mosquera Orgueira, Marta Sonia Gonzalez Perez, Mattia D'Agostino, David A Cairns, Alessandra Larocca, Ruth Wester

Hemasphere· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update and European consensus on a patient-centered core outcome set for multiple myeloma in clinical practice and research.
Simone Oerlemans, Belle H De Rooij, Christine Bennink, Lars Bullinger, Annemiek Broijl, Ruth Wester

Haematologica· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project.
Mattia D'Agostino, David A Cairns, Juan José Lahuerta, Ruth Wester, Uta Bertsch

J Clin Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment emergent peripheral neuropathy in the CASSIOPEIA trial.
Cathelijne Fokkema, Phillipe Moreau, Bronno Van der Holt, Jérôme Lambert, Mark Van Duin, Ruth Wester

Haematologica· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pomalidomide in Patients With Relapsed and/or Refractory Multiple Myeloma: A Prospective Study Within the Nationwide Netherlands Cancer Registry.
Ruth Wester, Avinash G Dinmohamed, Bronno van der Holt, Sonja Zweegman, Monique Minnema

Hemasphere· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma.
Pieter Sonneveld, Meletios A Dimopoulos, Meral Beksac, Bronno van der Holt, Sara Aquino, Ruth Wester

J Clin Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8 vs 4 Induction Cycles; the Carthadex Trial.
Ruth Wester, Sonja Zweegman, Bronno van der Holt, Marie José Kersten, Edo Vellenga

Hemasphere· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies.
Barbara Kiesewetter, Nathan I Cherny, Nicolas Boissel, Francesco Cerisoli, Urania Dafni, Ruth Wester

ESMO Open· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma; the Carthadex trial.
Ruth Wester, Bronno van der Holt, Emelie Asselbergs, Sonja Zweegman, Marie Jose Kersten

Haematologica· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovations in treatment and response evaluation in multiple myeloma.
Ruth Wester, Pieter Sonneveld

Haematologica· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease.
Inge A Hoevenaren, Ruth Wester, Robert W Schrier, Kim McFann, R Brian Doctor

Liver Int· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis